These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules. Yang SP, Nga ME, Bundele MM, Chiosea SI, Tan SH, Lum JHY, Parameswaran R, Lim MY, Li H, Cheah WK, Sek KS, Tan ATH, Loh TKS, Ngiam KY, Tan WB, Huang X, Ho TWT, Lim KH, Lim CM, Singaporewalla RM, Rao AD, Rao NCL, Chua DYK, Chin DC, Wald AI, LiVolsi VA, Nikiforov YE, Tai ES. Cancer Cytopathol; 2024 May; 132(5):309-319. PubMed ID: 38319805 [Abstract] [Full Text] [Related]
3. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China. Song Y, Xu G, Ma T, Zhu Y, Yu H, Yu W, Wei W, Wang T, Zhang B. Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686 [Abstract] [Full Text] [Related]
5. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules. Gortakowski M, Feghali K, Osakwe I. Thyroid; 2021 Sep; 31(9):1376-1382. PubMed ID: 33764195 [Abstract] [Full Text] [Related]
13. Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology. Skaugen JM, Taneja C, Liu JB, Wald AI, Nikitski AV, Chiosea SI, Seethala RR, Ohori NP, Karslioglu-French E, Carty SE, Nikiforova MN, Yip L, Nikiforov YE. Thyroid; 2022 Dec; 32(12):1500-1508. PubMed ID: 35864811 [Abstract] [Full Text] [Related]
14. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Nikiforova MN, Mercurio S, Wald AI, Barbi de Moura M, Callenberg K, Santana-Santos L, Gooding WE, Yip L, Ferris RL, Nikiforov YE. Cancer; 2018 Apr 15; 124(8):1682-1690. PubMed ID: 29345728 [Abstract] [Full Text] [Related]
15. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology. Barbosa TLM, Junior COM, Graf H, Cavalvanti T, Trippia MA, da Silveira Ugino RT, de Oliveira GL, Granella VH, de Carvalho GA. BMC Endocr Disord; 2019 Oct 29; 19(1):112. PubMed ID: 31664992 [Abstract] [Full Text] [Related]
17. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice. Witt RL. Del Med J; 2016 Dec 29; 88(12):366-372. PubMed ID: 29461717 [Abstract] [Full Text] [Related]
20. A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials. Zafereo M, McIver B, Vargas-Salas S, Domínguez JM, Steward DL, Holsinger FC, Kandil E, Williams M, Cruz F, Loyola S, Solar A, Roa JC, León A, Droppelman N, Lobos M, Arias T, Kong CS, Busaidy N, Grubbs EG, Graham P, Stewart J, Tang A, Wang J, Orloff L, Henríquez M, Lagos M, Osorio M, Schachter D, Franco C, Medina F, Wohllk N, Diaz RE, Veliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Traipe E, Marín L, Miranda G, Bruce E, Bracamonte M, Mena N, González HE. Thyroid; 2020 May 29; 30(5):704-712. PubMed ID: 31910118 [Abstract] [Full Text] [Related] Page: [Next] [New Search]